Colgate Palmolive Co

Company facts

Industry

Perfumes, Cosmetics & Other Toilet Preparations

Headquarters

New York, New York

Most recent report

10-Q, filed Jul 31, 2026

Incorporated

Delaware

Filings on record

1,002+ filings

On EDGAR

CIK 21665

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Jun 2026 10-Q

SECSift found 1 of 9 sections worth reading, with 1 positive, 2 notable, and 4 negative flags.

• Part I

  Full financials, restructuring, litigation, and segment detail for Q2 2026.
  Positive

  • Gross profit margin improved 140 bps to 61.5% in Q2 2026, driven by cost savings.
  Notable

  • Restructuring program incurred $305M pre-tax in H1 2026 ($129M in Q2); cumulative $318M to date. Total estimated charges $350-$550M.
  • ERISA litigation settled for $332M in January 2026; court allocated $99M to plaintiffs' attorneys' fees.
  Negative

  • Brazilian tax case: Federal Court of Appeals ruled against company on $19M dispute; appeals continue.
  • Talcum powder cases pending rose to 525 as of June 30, 2026, from 484 at March 31, 2026.
  • IRS tax dispute for 2010-2021 estimated at $168M (tax+interest) is not accrued; audit ongoing for 2019-2021.
  • North America net sales declined 3.0% in Q2 2026, with organic sales down 3.0% driven by the U.S.

What changed: Jun 2026 vs. Mar 2026

About 19% of CL's Jun 2026 10-Q is new information. 68 paragraphs were added, 159 changed, and 26 removed. Below are the most important lines SECSift identified.

• Part I 162
• Item 6 3
• Item 2 3
• Item 5 1